NAGE vs XEL · P/E 59, rev $61.3M vs P/E 20, $39.33B cap
Niagen Bioscience, Inc. (NAGE) versus Xcel Energy Inc (XEL) — a side-by-side from cached financials, not a winner call.
Niagen Bioscience, Inc. (NAGE) is a biotechnology company listed on US.
Xcel Energy Inc (XEL) is a utilities - regulated electric company listed on US.
Latest reported NAGE revenue for 2026-06-30 was $61.3M. Net income was $7.3M. Revenue was up 94.6% from 2026-03-31 to 2026-06-30. NAGE currently screens at market cap $836.5M and trailing P/E 59.0.
XEL does not have a complete income-statement cache yet.
NAGE currently screens at market cap $836.5M and trailing P/E 59.0. XEL currently screens at market cap $39.33B and trailing P/E 20.1.
Not investment advice. Open the NAGE and XEL stock pages for the full models.
Not investment advice.